Premium
Guidance regarding COVID‐19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group
Author(s) -
Verbruggen Lisanne C.,
Wang Yuehan,
Armenian Saro H.,
Ehrhardt Matthew J.,
Pal Helena J.H.,
Dalen Elvira C.,
van As Jorrit W.,
Bardi Edit,
Baust Katja,
Berger Claire,
Castagnola Elio,
Devine Katie A.,
Gebauer Judith,
Marchak Jordan Gilleland,
Glaser Adam W.,
Groll Andreas H.,
Haeusler Gabrielle M.,
den Hartogh Jaap,
Haupt Riccardo,
Hjorth Lars,
Kato Miho,
Kepák Tomáš,
Koopman Maria M.W. Rianne,
Langer Thorsten,
Maeda Miho,
Michel Gisela,
Muraca Monica,
Nathan Paul C.,
den Oever Selina R.,
Pavasovic Vesna,
Sato Satomi,
Schulte Fiona,
Sung Lillian,
Tissing Wim,
Uyttebroeck Anne,
Mulder Renée L.,
Kuehni Claudia,
Skinner Roderick,
Hudson Melissa M.,
Kremer Leontien C.M.
Publication year - 2020
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.28702
Subject(s) - medicine , guideline , harmonization , childhood cancer , cancer , covid-19 , medline , family medicine , young adult , statement (logic) , survivorship curve , pediatric cancer , pediatrics , gerontology , disease , pathology , infectious disease (medical specialty) , physics , political science , acoustics , law
Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID‐19. Little is known about the clinical course of COVID‐19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID‐19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID‐19.